                         SEQUENCE LISTING

<110>  NantOmics, LLC
 
<120>  UCK2 ASSAY TO PREDICT CANCER THERAPY RESPONSE

<130>  3900.0076I

<150>	62/560,764
<151>	09-20-2017

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  10
<212>  PRT
<213>  Homo sapiens

<400>  1

Leu Phe Val Asp Thr Asp Ala Asp Thr Arg 
1               5                   10  


